DNA-Encoded Libraries for the Discovery of Small-Molecule Hits
Drug Discovery Chemistry Conference 2023
DNA-Encoded library (DEL) screening is now commonly used in the pharmaceutical industry to find novel chemical matter that modulates protein targets of interest. Point-by-point, Dr. Alex Satz, Executive Director, WuXi Biology will discuss the primary challenges and limitations of DEL screening, and concisely state the current abilities of the technology and its potential.
Discover our end-to-end solutions platform for DEL screening.
Related Content
In our latest publication, WuXi AppTec scientists introduce two new methods that utilize readily accessible aldehydes to create substituted isoxazolines...
VIEW RESOURCEDNA-encoded library (DEL) technology has been recognized as a major screening method with unique advantages for offering vast chemical diversity...
VIEW RESOURCE